Charles River Laboratories International, Inc. CRL
292.84
(1.60)
(0.54%)
as of 25 Sep
- Market cap
- $14.1B
- P/E
- 0.0×
Follow CRL
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Charles River Laboratories International, Inc. (CRL) Price to free cash flow
As of 25 September 2026, Charles River Laboratories International, Inc. (CRL) trades at a price to free cash flow of 37.9×. Over the past ten years it has ranged from 9.0× (April 2025) to 50.0× (October 2021); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 34.0× and above the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 19.1× | 0.85% |
| FY2024 | 18.9× | (42.43%) |
| FY2023 | 32.8× | (12.72%) |
| FY2022 | 37.6× | 5.65% |
| FY2021 | 35.6× | 9.33% |
| FY2020 | 32.6× | 48.99% |
| FY2019 | 21.9× | 21.32% |
| FY2018 | 18.0× | (19.16%) |
| FY2017 | 22.3× | 62.11% |
| FY2016 | 13.8× | (10.38%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 29.4× | 36.17% |
| Mar 2026 | 21.6× | 13.17% |
| Dec 2025 | 19.1× | 34.64% |
| Sep 2025 | 14.2× | 9.87% |
| 42 more quarters | Free account |
Against its own ten years
Low 9.0×
High 50.0×
Ten-year median
22.0×
Current reading's percentile
91
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| TWST Twist Bioscience Corporation compare | n/m |
| ICLR ICON PLC compare | 15.0× |
| DGX Quest Diagnostics Incorporated compare | 19.4× |
| QGEN QIAGEN N.V. compare | 20.7× |
| LH Labcorp Holdings Inc. compare | 24.5× |
| MEDP Medpace Holdings, Inc. compare | 24.7× |
| RVTY Revvity Inc. compare | 29.8× |
| CRL Charles River Laboratories International, Inc. | 37.9× |
| Diagnostics & Research industry median | 34.0× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on CRL
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement